Eye

Orphan designation: Allogeneic cultured postnatal thymus-derived tissue Treatment of CHARGE syndrome, 26/02/2019 Positive

Retrieved on: 
Tuesday, April 9, 2024
Eurostat, Diagnosis, Civil service commission, Gene, Brain, Growth, Coloboma, Thymus, Patient, Committee, Knowledge, CHD7, Regulation, Child, Ventricular septal defect, EMA, IRIS, Eye, European, Infection, Therapy, COMP, Heart, Safety, European Commission, Spine, CHARGE syndrome, Nose, Genetic disorder, Sleep, Hearing, Medicine, Pharmaceutical industry

Orphan designation: Allogeneic cultured postnatal thymus-derived tissue Treatment of CHARGE syndrome, 26/02/2019 Positive

Key Points: 


Orphan designation: Allogeneic cultured postnatal thymus-derived tissue Treatment of CHARGE syndrome, 26/02/2019 Positive

Orphan designation: Autologous CD34+ cells transduced with a lentiviral vector encoding glucosylceramidase beta Treatment of Gaucher disease, 21/08/2020 Positive

Retrieved on: 
Tuesday, April 9, 2024
Eurostat, Diagnosis, Civil service commission, Brain, B cell, Gaucher's disease, Cell, CD34, Bone marrow, Bleeding, Disease, Seizure, Bruise, Patient, Committee, Knowledge, Fracture, Spleen, Regulation, Fatigue, Autotransplantation, EMA, IRIS, Human, Life expectancy, Eye, Bone pain, Anemia, European, COMP, Sponsor, European Commission, Safety, PPD, Marketing, Liver, Medicine, Pharmaceutical industry

Orphan designation: Autologous CD34+ cells transduced with a lentiviral vector encoding glucosylceramidase beta Treatment of Gaucher disease, 21/08/2020 Positive

Key Points: 


Orphan designation: Autologous CD34+ cells transduced with a lentiviral vector encoding glucosylceramidase beta Treatment of Gaucher disease, 21/08/2020 Positive

Orphan designation: Autologous CD34+ cells transduced with a lentiviral vector encoding galactosidase alpha Treatment of Fabry disease, 19/10/2020 Withdrawn

Retrieved on: 
Tuesday, April 9, 2024
Eurostat, Diagnosis, Civil service commission, Fabry disease, Brain, Cell, CD34, Disease, Nervous system, Patient, Committee, Knowledge, Tissue, Stroke, Kidney failure, Fats, Regulation, Autotransplantation, EMA, IRIS, Human, Eye, Sugar, European, Skin, COMP, Heart, Sponsor, European Commission, Enzyme replacement therapy, Blood, PPD, Pain, Safety, Marketing, Bone marrow, Medicine, Pharmaceutical industry

Orphan designation: Autologous CD34+ cells transduced with a lentiviral vector encoding galactosidase alpha Treatment of Fabry disease, 19/10/2020 Withdrawn

Key Points: 


Orphan designation: Autologous CD34+ cells transduced with a lentiviral vector encoding galactosidase alpha Treatment of Fabry disease, 19/10/2020 Withdrawn

Orphan designation: 3-(((1S,2S,3R)-2,3-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl)oxy)-5-fluorobenzonitrile Treatment of von Hippel-Lindau disease, 21/08/2020 Withdrawn

Retrieved on: 
Tuesday, April 9, 2024
Eurostat, Diagnosis, Civil service commission, Brain, Growth, Blood, Cell, Disease, Laser, Patient, Committee, Knowledge, Neoplasm, Regulation, EMA, IRIS, Eye, European, COMP, Pancreas, Spinal cord, Sponsor, European Commission, Von Hippel–Lindau disease, Gland, Safety, VHL, Marketing, DSM-IV codes, Medicine, Pharmaceutical industry

Orphan designation: 3-(((1S,2S,3R)-2,3-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl)oxy)-5-fluorobenzonitrile Treatment of von Hippel-Lindau disease, 21/08/2020 Withdrawn

Key Points: 


Orphan designation: 3-(((1S,2S,3R)-2,3-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl)oxy)-5-fluorobenzonitrile Treatment of von Hippel-Lindau disease, 21/08/2020 Withdrawn

OceanBlue Omega Unveils its Essentials Series to Boost Omega-3 Supplementation

Retrieved on: 
Monday, March 25, 2024
Health, Eye, Summer, The Essential Series, Science, Dietary supplement

OceanBlue Omega , a leading manufacturer and distributor of premium high-potency omega-3 supplements, announced today the launch of its Essentials Series, a pioneering range of omega-3 supplements designed for universal appeal.

Key Points: 
  • OceanBlue Omega , a leading manufacturer and distributor of premium high-potency omega-3 supplements, announced today the launch of its Essentials Series, a pioneering range of omega-3 supplements designed for universal appeal.
  • “Omega-3s are fundamental to our well-being, affecting everything from brain health to immune response,” said Daniel Wiley, President of OceanBlue Omega.
  • The Essentials Series supplements are crafted to benefit individuals of every age, embodying OceanBlue’s belief in the universal importance of omega-3s.
  • To see the Essential Series, click here: Essentials Series .

At the Yacht Club de Monaco yachts become ‘smarter’

Retrieved on: 
Monday, March 25, 2024
Award, Environment, Recycling, Carbon footprint, Yacht Club de Monaco, UBS, Wind, Eye, Hydrogen, Water, Composite, Prince

MONACO, March 25, 2024 (GLOBE NEWSWIRE) -- Yacht Club de Monaco are promoting sustainable solutions for the luxury yachting sector.

Key Points: 
  • MONACO, March 25, 2024 (GLOBE NEWSWIRE) -- Yacht Club de Monaco are promoting sustainable solutions for the luxury yachting sector.
  • It is the aim of the Monaco Smart Yacht Rendezvous supported by Ubs, Sindalah, the shipyards MB92 Group and Wider Yachts.
  • Among 350 participants, 5 finalists in startup and scaleup categories were selected by a jury of experts for the Smart Innovative Yacht Awards.
  • Organised in collaboration with the Prince Albert II of Monaco Foundation, the event gathered innovation experts, architects and yachting enthusiasts from all over the world.

Sir Bofi - Unheard and Unfair Advantages Launching April 2024

Retrieved on: 
Wednesday, March 20, 2024
Microsoft, Reward, DEX, Ecosystem, CEX, Risk, Microsoft Windows, Marketing, Sale, Magic, Eye

Thus is the scenario with Sir Bofi if we're talking trading speed.

Key Points: 
  • Thus is the scenario with Sir Bofi if we're talking trading speed.
  • Like a magician reaching into a seemingly inexhaustible hat, Sir Bofi is already working on a WalletConnectV2 integration and Token Gating.
  • Because, you know, being the fastest wasn't enough.x
    And before you ask, yes, Sir Bofi likes the sound of his token.
  • It’s pulled up and ready for use in the impending Sir Bofi Web Platform for subscription payments and Token Gating.

US Retinal Specialists Highlight the Greatest Opportunity for Gene Therapies

Retrieved on: 
Tuesday, March 19, 2024
Retina, Stargardt disease, Macular edema, Retinitis pigmentosa, Eye, Intelligence, Paratriathlon, Hope, Stargardt, Adverum Biotechnologies, Safety, NAMD, Geographic atrophy, Ophthalmology, Diabetic retinopathy, Medical device

Unlike other organs, the eye's compact size and accessibility have made it an ideal application for gene therapies, offering targeted treatment with minimal systemic impact.

Key Points: 
  • Unlike other organs, the eye's compact size and accessibility have made it an ideal application for gene therapies, offering targeted treatment with minimal systemic impact.
  • As advancements continue, a plethora of gene therapies for retinal disorders are on the horizon.
  • Spherix Global Insights collaborated with 77 retinal specialists to understand their perspectives on adopting gene therapies, specifically where specialists were and were not willing to use gene therapy across diseases and patient types.
  • While retinal specialists express eagerness for gene therapies, dissatisfaction towards current treatments like Syfovre and Izervay underscores the need for innovation.

Ibotta Debuts Experiential Campaign, Surprises Consumers with Cash Back Giveaways Nationwide

Retrieved on: 
Tuesday, March 19, 2024
Pressure, Augmented reality, Social media, Life, Savers, Ball Arena, Eye, City, Online shopping

DENVER, March 19, 2024 (GLOBE NEWSWIRE) -- Ibotta , a leading cash back rewards and performance marketing platform, today debuted its Make It Rain experiential campaign.

Key Points: 
  • DENVER, March 19, 2024 (GLOBE NEWSWIRE) -- Ibotta , a leading cash back rewards and performance marketing platform, today debuted its Make It Rain experiential campaign.
  • Consumers in New York, Chicago and Denver will be gifted with free cash back at eye-catching in-person activations while shoppers nationwide can earn additional cash back online through augmented reality (AR) experiences.
  • ​​Inspired by Ibotta's tagline, 'Cash back every time you shop,' the campaign showers consumers in cash, mirroring how Ibotta users earn cash back with each purchase.
  • "Cash, cash, and more cash," continued Donahue, "we're just trying to do our part with our retail and brand partners to ease some of the pressure on the consumer."

New Study from eye square and Screenforce Shows Varying Levels of Advertising Effectiveness at Different Times of Day

Retrieved on: 
Tuesday, March 19, 2024
Research, Partnership, Eye, Advertising research, Advertising, Family, Emotion, Television

The findings were chosen for presentation at the Advertising Research Foundation’s upcoming “ARF 2024 AUDIENCExSCIENCE” conference event in New York on March 20.

Key Points: 
  • The findings were chosen for presentation at the Advertising Research Foundation’s upcoming “ARF 2024 AUDIENCExSCIENCE” conference event in New York on March 20.
  • In the recent study, eye square and Screenforce conducted a media ethnography to measure viewer attention in their living rooms.
  • “The effectiveness of advertising spots depends on the situation in which they are viewed,” said Jeff Bander, president of eye square.
  • “Our new research combines detailed, qualitative viewer feedback with objective tracking of eye and head movements to provide clear takeaways on advertising impact.